BioSpace News Archive

Biotricity, Inc. announced that it will release its financial results for the third quarter of fiscal 2022, ended December 31, 2021, on Monday, February 14, 2022.

MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics™), today announced a groundbreaking partnership with the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH)-funded Cardiothoracic Surgical Trials Network (CTSN) to participate in a multicenter randomized clinical trial substudy of its PocketECG® technology.

Model Medicines, today announced preclinical results demonstrating once daily, oral dosing of MDL-001 significantly reduces the viral load of SARS-CoV-2 (the virus that causes COVID-19) in the lungs of an established mouse-adapted animal model of SARS-CoV-2 infection (two-way ANOVA, P < 0.01).

Fractyl Health, an organ-editing metabolic therapeutics company focused on pioneering a new approach to the treatment of type 2 diabetes (T2D), announced today a decision from InEK in Germany that Revita has been granted Status 1 designation under its NUB funding process.

Cyclo Therapeutics Selected to Present Overview of Pivotal Phase 3 Study for Lead Candidate, Trappsol ® Cyclo™, at WORLD Symposium 2022.

C2i Genomics and Twist Bioscience Corporation today announced a partnership to develop whole-genome cancer reference materials.

Trestle Biotherapeutics today announced that it has entered into a license agreement with Harvard University.

Strand Therapeutics today announced that Prashant Nambiar, DVM, PhD, MBA has been appointed Senior Vice President, Research and Translational Development.

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that management will present a company overview at the 11th Annual SVB Leerink Global Healthcare Conference, being held virtually, on Thursday, February 17, 2022 at 10:00 am ET.

Carestream Health’s groundbreaking Smart Noise Cancellation (SNC) technology has received FDA 510(k) Clearance for its dose reduction capability.